How should I evaluate and treat blood‑filled blisters on the arch of the feet that are suspected to be bullous pemphigoid?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Evaluation and Treatment of Blood-Filled Blisters on the Arch of the Feet Suspected to be Bullous Pemphigoid

For blood-filled blisters on the arch of the feet suspected to be bullous pemphigoid, you must obtain a perilesional skin biopsy for direct immunofluorescence (DIF) microscopy—this is the most critical diagnostic test and is essential for confirming BP—along with a lesional biopsy for histopathology, and serum testing for anti-BP180 antibodies by ELISA. 1

Diagnostic Workup

Essential Diagnostic Tests

The diagnosis of BP requires a combination of clinical features plus laboratory confirmation. You need three components:

  1. Direct Immunofluorescence (DIF) - Take a perilesional biopsy (from non-blistered skin immediately adjacent to a blister). This is the most critical test; positivity is essential for diagnosis. You're looking for linear IgG and/or C3 deposits along the dermoepidermal junction. 1

  2. Histopathology - Biopsy an early intact blister arising on erythematous skin and place in formalin. Typical findings include subepidermal bullae containing eosinophils and/or neutrophils with a dermal infiltrate of eosinophils. 1

  3. Serology - Order anti-BP180 IgG antibodies by ELISA. If negative, test for anti-BP230 antibodies. Alternatively, indirect immunofluorescence on salt-split skin showing IgG binding to the epidermal side confirms the diagnosis. 1

Clinical Features to Document

Look for these specific characteristics that support BP diagnosis:

  • Age > 70 years
  • Absence of atrophic scars
  • Absence of mucosal involvement
  • Absence of predominant bullous lesions on neck and head

When three of these four criteria are present along with positive DIF, you can diagnose BP with high specificity and sensitivity. 1

Important Pitfall in Diabetic Patients

Be aware that in diabetic patients with foot wounds, BP can mimic postoperative infection or ischemia. If you see sudden onset of sterile tense bullae extending beyond pressure areas or lacking typical inflammatory signs of infection, strongly consider BP and obtain early biopsy with DIF. This prevents unnecessary antimicrobial escalation or surgical intervention. 2

Treatment Approach

For Localized Disease (Arch of Feet Only)

Start with topical clobetasol propionate 0.05% cream or ointment 10-20 g daily applied to lesional skin only. 1 This is the preferred initial treatment for localized BP.

  • Apply once daily to affected areas and surrounding skin
  • Reduce dose 15 days after achieving disease control
  • Gradually taper with the goal of stopping treatment 4-12 months after initiation 1
  • If no disease control within 1-3 weeks, increase to 40 g daily 1

If Disease Extends Beyond Feet

If blisters are disseminated across multiple body sites, apply clobetasol propionate 0.05% cream 20-40 g daily over the entire body surface (except face: 10 g daily). 1 This approach is superior to systemic steroids.

The landmark evidence shows that whole-body topical clobetasol propionate compared to oral prednisone:

  • Probably increases skin healing at day 21 (99.8% vs 92.4%) 3
  • May reduce mortality at one year (26.5% vs 36.3%) 3
  • May reduce severe complications 3

Alternative for Patients with Comorbidities

For patients with diabetes, hypertension, chronic kidney disease, or other significant comorbidities where corticosteroids pose high risk, use doxycycline 200 mg daily. 4, 3

While doxycycline is less effective for skin healing than prednisolone (73.8% vs 91.1% complete healing at 6 weeks), it provides critical mortality benefit:

  • Decreases mortality at one year (2.4% vs 9.7%; NNT = 14) 3
  • Improves quality of life 3
  • Reduces severe or life-threatening treatment-related adverse events 3

This makes doxycycline the safer choice when systemic immunosuppression must be avoided. 2

Systemic Steroids (Use Cautiously)

If topical therapy fails or is not feasible:

  • Prednisone 0.5-0.75 mg/kg/day is effective but associated with higher mortality and side effects compared to topical clobetasol 1
  • Doses < 0.5 mg/kg are ineffective and not recommended 1
  • The 1 mg/kg dose previously used is no longer recommended due to excessive mortality 1

Adjunctive Measures

  • Use antiseptic baths with or without wheat starch 1
  • Cover extensive erosive lesions with nonadherent dressings to reduce bacterial superinfection, decrease pain, and promote healing 1

Key Clinical Pearls

  • DIF is non-negotiable - you cannot diagnose BP without it 1
  • Topical steroids are first-line even for extensive disease when feasible 1, 3
  • In diabetic foot patients, maintain high suspicion for BP when blisters appear sterile and extend beyond expected areas 2
  • Mortality matters more than rapid healing - choose doxycycline over systemic steroids in high-risk patients 3
  • Blood-filled blisters (hemorrhagic bullae) are a recognized variant of BP and don't change the diagnostic or treatment approach 5

budget:token_budget Tokens used this turn: 0 (0 for processing evidence + 0 for response) Total tokens used in conversation: 0 Remaining token budget: 200000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.